PDK3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.090000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.043200E-01
Normal-vs-Stage2
9.547400E-01
Normal-vs-Stage3
3.767200E-01
Normal-vs-Stage4
8.287200E-01
Stage1-vs-Stage2
2.207000E-01
Stage1-vs-Stage3
2.532400E-01
Stage1-vs-Stage4
4.746800E-01
Stage2-vs-Stage3
3.494200E-01
Stage2-vs-Stage4
8.166400E-01
Stage3-vs-Stage4
5.988400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.654600E-01
Normal-vs-AfricanAmerican
7.832400E-01
Normal-vs-Asian
2.269200E-01
Caucasian-vs-AfricanAmerican
5.742800E-01
Caucasian-vs-Asian
8.098500E-03
AfricanAmerican-vs-Asian
4.377000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.669600E-01
Normal-vs-Female
8.414000E-01
Male-vs-Female
4.985400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.981800E-01
Normal-vs-Age(41-60Yrs)
5.840800E-01
Normal-vs-Age(61-80Yrs)
9.801400E-01
Normal-vs-Age(81-100Yrs)
3.395200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.389400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.955600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.521400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.983900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.664000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.173640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.219600E-01
Normal-vs-Daily Drinker
9.448600E-01
Normal-vs-Weekly Drinker
3.979400E-01
Normal-vs-Occasional Drinker
5.885600E-01
Normal-vs-Social Drinker
8.236000E-01
Non Drinker-vs-Daily Drinker
3.452400E-01
Non Drinker-vs-Weekly Drinker
7.811200E-01
Non Drinker-vs-Occasional Drinker
7.912300E-02
Non Drinker-vs-Social Drinker
1.833790E-01
Daily Drinker-vs-Weekly Drinker
2.355600E-01
Daily Drinker-vs-Occasional Drinker
1.875560E-01
Daily Drinker-vs-Social Drinker
5.736400E-01
Weekly Drinker-vs-Occasional Drinker
5.888500E-02
Weekly Drinker-vs-Social Drinker
1.361610E-01
Occasional Drinker-vs-Social Drinker
3.502000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.053800E-01
Normal-vs-Grade 2
3.110400E-01
Normal-vs-Grade 3
2.726800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.306400E-01
Grade 1-vs-Grade 3
6.933800E-01
Grade 1-vs-Grade 4
5.053800E-01
Grade 2-vs-Grade 3
6.441000E-01
Grade 2-vs-Grade 4
3.110400E-01
Grade 3-vs-Grade 4
2.726800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.831600E-01
Normal-vs-NonDiabetic
9.855200E-01
Diabetic-vs-NonDiabetic
4.774200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.873600E-01
Normal-vs-NoPancreatitis
9.187000E-01
Pancreatitis-vs-NoPancreatitis
3.957400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.171800E-01
Normal-vs-N1
9.956600E-01
N0-vs-N1
3.901000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.950400E-01
Normal-vs-TP53-NonMutant
9.999000E-01
TP53-Mutant-vs-TP53-NonMutant
4.956800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
